Multiple sclerosis (MS) is a chronic illness that damages nerves in the brain and spinal cord. In this disease, the body’s immune system mistakenly targets and attacks the myelin in the central nervous system, or the layer of insulation around the nerves. As the autoantibodies target healthy myelin tissue, neurological disabilities ensue. While there is currently no cure for MS nor any means of repairing myelin damage to improve disease progression, results from clinical trials suggest mesenchymal stem cells (MSCs) could be effective in treating nerve damage caused by the condition. So many may be wondering “Can Stem Cells treat neural damage caused by Multiple Sclerosis”.
According to researchers, MSCs can help to control the immune response in people with Multiple Sclerosis. These cells have powerful self-renewal capabilities, in addition to immunomodulatory and neuroregenerative properties. While the precise cellular mechanisms of stem cells in treating Multiple Sclerosis are still being studied, researchers are encouraged by the results of several clinical trials thus far.
For instance, MSCs can be targeted to the brain tissues to reach the sites of damage, including brain lesions, to help improve the survival rate of brain cells. Also administered systemically, these cells have the potential to improve one’s quality of life and severity of symptoms.
Stem cells can be retrieved from various sources, including fat tissue, umbilical cord-derived tissue, and bone marrow aspirate. The mesenchymal stem cells derived from these tissues provide the potential power in improving cognitive function and decreasing disease severity, which is likely due to the cells’ anti-inflammatory and neuroprotective characteristics. The source of cells is determined by a few factors including age, medical history, and patient preference. Results can vary from patient to patient. Their environment factors, diet, and lifestyle choices can play an important part in the outcome. However, studies have shown that stem cell therapy for those whose immune systems have been compromised has the potential to prohibit the progression of MS for up to five years in 70% to 80% of patients. This and other stem cell treatments have the potential to significantly improve treatment outcomes for people with MS. Contact a Care Coordinator today for a free assessment!